Adamantinomatous Craniopharyngioma
3 clinical trials · Condition
◉ Watch Adamantinomatous Craniopharyngioma
| Record | Firm | Date |
|---|---|---|
| FOG-001 in Locally Advanced or Metastatic Solid Tumors (NCT05919264) | Parabilis Medicines, Inc. | 2023-05-23 |
| ACTEMRA® for the Treatment of Pediatric Adamantinomatous Craniopharyngioma (NCT05233397) | Nationwide Children's Hospital | 2022-12-16 |
| Tocilizumab in Children With ACP (NCT03970226) | University of Colorado, Denver | 2019-09-16 |
Track Adamantinomatous Craniopharyngioma automatically
Every clearance here is in the API, with alerts when new ones post.